Literature DB >> 6142751

Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

C R Hind, C O Savage, C G Winearls, M B Pepys.   

Abstract

Serial measurements of the serum concentration of C reactive protein were made in 27 patients with polyarteritis over six years. The concentration was invariably raised when the disease was active, even in patients receiving immunosuppressive treatment, and fell rapidly in association with clinical remission induced by immunosuppression. During periods of complete remission, in the absence of any intercurrent condition, the value remained within the normal range. The correlation between C reactive protein concentration and disease activity was much closer than that between erythrocyte sedimentation rate and disease activity. These results indicate that serial measurement of the serum C reactive protein concentration fills the urgent need for an objective index of the activity of polyarteritis and its response to treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142751      PMCID: PMC1442625          DOI: 10.1136/bmj.288.6423.1027

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

2.  Clinical features, prognosis, and response to treatment in polyarteritis.

Authors:  R D Cohen; D L Conn; D M Ilstrup
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

3.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

4.  Solid-phase immunoradiometric assay for C-reactive protein using magnetisable cellulose particles.

Authors:  F C De Beer; M B Pepys
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

5.  Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases.

Authors:  D G Scott; P A Bacon; P J Elliott; C R Tribe; T B Wallington
Journal:  Q J Med       Date:  1982

6.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

7.  Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.

Authors:  R K Mallya; D Vergani; D E Tee; L Bevis; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

8.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.

Authors:  F C de Beer; C R Hind; K M Fox; R M Allan; A Maseri; M B Pepys
Journal:  Br Heart J       Date:  1982-03

9.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

10.  Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in goodpasture's syndrome.

Authors:  P W Ewan; H A Jones; C G Rhodes; J M Hughes
Journal:  N Engl J Med       Date:  1976-12-16       Impact factor: 91.245

View more
  10 in total

1.  Effect of short-term aspirin use on C-reactive protein.

Authors:  D Feng; R P Tracy; I Lipinska; J Murillo; C McKenna; G H Tofler
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

Review 2.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

3.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 4.  Assessment of disease activity in systemic vasculitis.

Authors:  W Y Tse; P Cockwell; C O Savage
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 5.  Renal vasculitis: a review.

Authors:  G Neild
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

6.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

7.  Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity.

Authors:  N Hurt; T Smith; T Teuscher; M Tanner
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

8.  Serum C-reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis.

Authors:  C R Hind; S P Thomson; C G Winearls; M B Pepys
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

9.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

10.  Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides.

Authors:  W Egner; H M Chapel
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.